Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●(See "Society guideline links: Myocarditis".)
●(See "Society guideline links: Acute rheumatic fever and rheumatic heart disease".)
●(See "Society guideline links: Transcatheter aortic valve implantation".)
●(See "Society guideline links: Acute extremity ischemia".)
●(See "Society guideline links: Bicuspid aortic valve".)
International
●American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), Japanese Society of Echocardiography (JSE), and Society for Cardiovascular Magnetic Resonance (SCMR): Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement (2019)
Canada
●Choosing Wisely Canada: Don't perform echocardiography as routine follow-up for mild, asymptomatic native valve disease in adult patients with no change in signs or symptoms (2021)
●Canadian Cardiovascular Society (CCS): Position statement on transcatheter aortic valve implantation (2012)
United States
●Choosing Wisely: Avoid performing echocardiography as routine follow-up for mild, asymptomatic native valve disease in adult patients with no change in signs or symptoms (2021)
●American College of Cardiology (ACC)/American Heart Association (AHA): Guideline for the management of patients with valvular heart disease (2020)
●American Association for Thoracic Surgery (AATS), ACC, American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), and Society of Thoracic Surgeons (STS): Expert consensus systems of care document – A proposal to optimize care for patients with valvular heart disease (2019)
●ASE, SCAI, Japanese Society of Echocardiography (JSE), and Society for Cardiovascular Magnetic Resonance (SCMR): Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement (2019)
●Society of Cardiovascular Computed Tomography (SCCT): An expert consensus document for computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR) (2019)
●American College of Surgeons (ACS): Guidelines for the perioperative management of antithrombotic medication (2018)
●AATS: Consensus guidelines on ischemic mitral valve regurgitation, 2016 update (published 2017)
●ACC/AATS/AHA/ASE/American Society of Nuclear Cardiology (ASNC)/Heart Rhythm Society (HRS)/SCAI/SCCT/SCMR/STS: Appropriate use criteria for multimodality imaging in valvular heart disease (2017)
●ACC/AATS/AHA/ASE/European Association for Cardio-Thoracic Surgery (EACTS)/Heart Valve Society (HVS)/Society of Cardiovascular Anesthesiologists (SCA)/SCAI/SCCT/SCMR/STS: Appropriate use criteria for the treatment of patients with severe aortic stenosis (2017)
●American College of Radiology (ACR): ACR Appropriateness Criteria on imaging for transcatheter aortic valve replacement (2017)
●An expert statement for diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors (2017)
●ASE and Society for Cardiovascular Magnetic Resonance (SCMR): Recommendations for noninvasive evaluation of native valvular regurgitation (2017)
●European Association of Cardiovascular Imaging (EACVI)/ASE: Recommendations on the echocardiographic assessment of aortic valve stenosis, a focused update (2017)
•EAE (European Association of Echocardiography)/ASE: Echocardiographic assessment of valve stenosis − Recommendations for clinical practice (2009)
●AHA: Scientific statement on infective endocarditis in adults − Diagnosis, antimicrobial therapy, and management of complications (2015)
●AHA/ACC: Scientific statement − Eligibility and disqualification criteria for athletes with cardiovascular abnormalities (2015)
●Choosing Wisely: Avoid prophylactic antibiotics for the treatment of mitral valve prolapse (2015)
●SCAI, AATS, ACC, and STS: Expert consensus statement on operator and institutional requirements for transcatheter valve repair and replacement − Part III: Pulmonic valve (2015)
●AHA/ACC: Valve disease guideline on new stages of disease, new treatment options, and a call for earlier intervention (2014)
●ACC, AATS, SCAI, and STS: Clinical guidelines on transcatheter therapies for mitral regurgitation (2013)
●Choosing Wisely: Don't order follow up or serial echocardiograms for surveillance after a finding of trace valvular regurgitation on an initial echocardiogram (2013)
●Choosing Wisely: Don't perform a routine pre-discharge echocardiogram after cardiac valve replacement surgery (2013)
●AATS, ACCF, SCAI, and STS: Multisociety expert consensus statement on operator and institutional requirements for transcatheter valve repair and replacement − Part 1: Transcatheter aortic valve replacement (2012)
●ACCF/AATS/SCAI/STS: Expert consensus document on transcatheter aortic valve replacement (2012)
●ACCF/SCAI/AATS/AHA/ASE/ASNC/Heart Failure Society of American (HFSA)/HRS/Society of Critical Care Medicine (SCCM)/SCCT/SCMR/STS: Appropriate use criteria for diagnostic catheterization (2012)
●American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines on antithrombotic and thrombolytic therapy for valvular disease − Antithrombotic therapy and prevention of thrombosis, 9th edition (2012)
●ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR: Appropriate use criteria for echocardiography (2011)
●EAE/ASE: Recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease (2011)
●ASE: Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound (2009)
●EAE/ASE: Echocardiographic assessment of valve stenosis − Recommendations for clinical practice (2009)
Europe
●European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS): Guidelines for the management of valvular heart disease (2021)
●ESC: Guidelines for the management of cardiovascular diseases during pregnancy (2018)
●European Association of Cardiovascular Imaging (EACVI)/American Society of Echocardiography (ASE): Recommendations on the echocardiographic assessment of aortic valve stenosis, a focused update (2017)
•European Association of Echocardiography (EAE)/ASE: Echocardiographic assessment of valve stenosis − Recommendations for clinical practice (2009)
●European Heart Rhythm Association (EHRA) and ESC: A joint consensus document for antithrombotic therapy in atrial fibrillation associated with valvular heart disease (2017)
●ESC: Position statement for the management of tricuspid valve regurgitation (2017)
●ESC: Guidelines for the management of infective endocarditis (2015)
●ESC: Clinical practice guidelines on aortic diseases (2014)
●ESC, EHRA, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA): Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve intervention (2014)
●EAE/ASE: Recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease (2011)
●EAE: Recommendations for the assessment of valvular regurgitation − Part 1: Aortic and pulmonary regurgitation (native valve disease) (2010)
●EAE: Recommendations for the assessment of valvular regurgitation − Part 2: Mitral and tricuspid regurgitation (native valve disease) (2010)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on transcatheter tricuspid valve leaflet repair for tricuspid regurgitation (2022)
●NICE: Interventional procedures guidance on transcatheter tricuspid valve annuloplasty for tricuspid regurgitation (2022)
●NICE: Clinical guideline on acute heart failure − Diagnosis and management (2014, updated 2021)
●NICE: Guideline on heart valve disease presenting in adults − Investigation and management (2021)
●NICE: Interventional procedures guidance on percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve (2021)
●NICE: Interventional procedures guidance on transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair (2021)
●NICE: Interventional procedures guidance on transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis (2021)
●NICE: Interventional procedures guidance for percutaneous mitral valve leaflet repair for mitral regurgitation (2019)
●NICE: Guideline on chronic heart failure in adults – Diagnosis and management (2018)
●NICE: Interventional procedures guidance for aortic valve reconstruction with processed bovine pericardium (2018)
●NICE: Interventional procedures guidance on percutaneous balloon valvuloplasty for fetal critical aortic stenosis (2018)
●NICE: Interventional procedures guidance on sutureless aortic valve replacement for aortic stenosis (2018)
●NICE: Quality standard on chronic heart failure in adults (2011, updated 2018)
●NICE: Interventional procedures guidance on transcatheter aortic valve implantation for aortic stenosis (2017)
●NICE: Clinical guideline on prophylaxis against infective endocarditis − Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (2008, updated 2016)
●NICE: Interventional procedures guidance on balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (2016)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on the management of chronic heart failure (2016)
●NICE: Quality standard on acute heart failure (2015)
●NICE: Interventional procedures guidance on transcatheter valve-in-valve implantation for aortic bioprosthetic valve dysfunction (2014)
●NICE: Interventional procedures guidance on percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction (2013)
●NICE: Interventional procedures guidance on percutaneous mitral valve annuloplasty (2010)
●NICE: Interventional procedures guidance on percutaneous mitral valve leaflet repair for mitral regurgitation (2009)
●NICE: Interventional procedures guidance on thoracoscopically assisted mitral valve surgery (2007)
●NICE: Interventional procedures guidance on balloon dilatation of pulmonary valve stenosis (2004)
●NICE: Interventional procedures guidance on balloon valvuloplasty for aortic valve stenosis in adults and children (2004)
Australia–New Zealand
●Cardiac Society of Australia and New Zealand (CSANZ): Diagnosis and management of inherited aortopathies, including Marfan syndrome, update (2016)
Japan
●[In English] American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), Japanese Society of Echocardiography (JSE), and Society for Cardiovascular Magnetic Resonance (SCMR): Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement (2019)
●[In Japanese] Japanese Circulation Society (JCS): Guidelines for the prevention and treatment of infective endocarditis (2017)
●[In English] Japan Society of Ultrasonics in Medicine (JSUM): Echocardiographic diagnosis of adult valvular heart disease (2016)
